Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


31.07.2017

1 Am J Manag Care
1 Atherosclerosis
2 Biochem Biophys Res Commun
5 Diabet Med
6 Diabetes
14 Diabetes Care
1 Diabetes Educ
5 Diabetes Obes Metab
2 Diabetologia
2 Invest Ophthalmol Vis Sci
2 J Am Coll Cardiol
1 J Am Soc Nephrol
3 J Diabetes Complications
1 JAMA
1 Kidney Int
5 Lancet Diabetes Endocrinol
2 Metabolism
3 N Engl J Med
3 Pediatr Diabetes
12 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Manag Care

  1. LIU J, Brown J, Morton S, Potter DEB, et al
    Disparities in diabetes and hypertension care for individuals with serious mental illness.
    Am J Manag Care. 2017;23:304-308.
    PubMed     Text format     Abstract available


    Atherosclerosis

  2. ESTRUCH M, Minambres I, Sanchez-Quesada JL, Soler M, et al
    Increased inflammatory effect of electronegative LDL and decreased protection by HDL in type 2 diabetic patients.
    Atherosclerosis. 2017 Jul 13. pii: S0021-9150(17)31190.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  3. YI F, Shang Y, Li B, Dai S, et al
    MicroRNA-193-5p modulates angiogenesis through IGF2 in type 2 diabetic cardiomyopathy.
    Biochem Biophys Res Commun. 2017 Jul 20. pii: S0006-291X(17)31466.
    PubMed     Text format     Abstract available

  4. WANG G, Gu Y, Xu N, Zhang M, et al
    Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: Association with ongoing islet autoimmunity.
    Biochem Biophys Res Commun. 2017 Jul 18. pii: S0006-291X(17)31328.
    PubMed     Text format     Abstract available


    Diabet Med

  5. INGRAM JR, Cawley S, Coulman E, Gregory C, et al
    Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study).
    Diabet Med. 2017 Jul 22. doi: 10.1111/dme.13431.
    PubMed     Text format     Abstract available

  6. VLOEMANS AF, van Beers CAJ, de Wit M, Cleijne W, et al
    Keeping safe. Continuous glucose monitoring (CGM) in persons with Type 1 diabetes and impaired awareness of hypoglycaemia: a qualitative study.
    Diabet Med. 2017 Jul 21. doi: 10.1111/dme.13429.
    PubMed     Text format     Abstract available

  7. KIM CW, Chang Y, Sung E, Ryu S, et al
    Sleep duration and progression to diabetes in people with prediabetes defined by HbA1c concentration.
    Diabet Med. 2017 Jul 22. doi: 10.1111/dme.13432.
    PubMed     Text format     Abstract available

  8. BJORNSTAD P, Costacou T, Miller RG, Maahs DM, et al
    Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies.
    Diabet Med. 2017 Jul 22. doi: 10.1111/dme.13430.
    PubMed     Text format     Abstract available

  9. BARBER SR, Dhalwani NN, Davies MJ, Khunti K, et al
    External national validation of the Leicester Self-Assessment score for Type 2 diabetes using data from the English Longitudinal Study of Ageing.
    Diabet Med. 2017 Jul 26. doi: 10.1111/dme.13433.
    PubMed     Text format     Abstract available


    Diabetes


  10. In This Issue of Diabetes.
    Diabetes. 2017;66:2061-2062.
    PubMed     Text format    

  11. FAN Y
    Bait and Trap: Enriching Autoreactive T Cells With beta-Cell Antigen-Loading Biomaterial Scaffolds for Early Detection of Type 1 Diabetes.
    Diabetes. 2017;66:2066-2068.
    PubMed     Text format    

  12. ABBASI A
    Comment on Muka et al. Associations of Steroid Sex Hormones and Sex Hormone-Binding Globulin With the Risk of Type 2 Diabetes in Women: A Population-Based Cohort Study and Meta-analysis. Diabetes 2017;66:577-586.
    Diabetes. 2017;66:e7.
    PubMed     Text format    

  13. MOLLAH ZU, Quah HS, Graham KL, Jhala G, et al
    Granzyme A-deficiency breaks immune tolerance and promotes Autoimmune Diabetes Through a Type I Interferon-Dependent Pathway.
    Diabetes. 2017 Jul 21. pii: db170517. doi: 10.2337/db17-0517.
    PubMed     Text format     Abstract available

  14. CHENG J, Song J, He X, Zhang M, et al
    Erratum. Loss of Mbd2 Protects Mice Against High-Fat Diet-Induced Obesity and Insulin Resistance by Regulating the Homeostasis of Energy Storage and Expenditure Diabetes 2016;65:3384-3395.
    Diabetes. 2017 Jul 26. pii: db17er09b. doi: 10.2337.
    PubMed     Text format    

  15. JHA JC, Banal C, Okabe J, Gray SP, et al
    NADPH Oxidase-Nox5 Accelerates Renal Injury in Diabetic Nephropathy.
    Diabetes. 2017 Jul 26. pii: db161585. doi: 10.2337/db16-1585.
    PubMed     Text format     Abstract available


    Diabetes Care

  16. LAURI C, Tamminga M, Glaudemans AWJM, Juarez Orozco LE, et al
    Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET.
    Diabetes Care. 2017;40:1111-1120.
    PubMed     Text format     Abstract available

  17. CEFALU WT
    Diabetes Care: Change Is Constant, Part 2.
    Diabetes Care. 2017;40:991-993.
    PubMed     Text format    


  18. In This Issue of Diabetes Care.
    Diabetes Care. 2017;40:989-990.
    PubMed     Text format    

  19. ABDUL-GHANI M, DeFronzo RA
    Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm.
    Diabetes Care. 2017;40:1121-1127.
    PubMed     Text format     Abstract available

  20. INZUCCHI SE
    Is It Time to Change the Type 2 Diabetes Treatment Paradigm? No! Metformin Should Remain the Foundation Therapy for Type 2 Diabetes.
    Diabetes Care. 2017;40:1128-1132.
    PubMed     Text format     Abstract available

  21. LUO K, Fang W, Xu G
    Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390.
    Diabetes Care. 2017;40:e108.
    PubMed     Text format    

  22. NIEWCZAS MA, Krolewski AS
    Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390.
    Diabetes Care. 2017;40:e109-e110.
    PubMed     Text format    

  23. HERING BJ, Bridges ND, Eggerman TL, Ricordi C, et al
    Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072-1074.
    Diabetes Care. 2017;40:e111-e112.
    PubMed     Text format    

  24. HARLAN DM
    Response to Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072-1074.
    Diabetes Care. 2017;40:e113-e114.
    PubMed     Text format    

  25. BARBOUR LA, Davies JK
    Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332-337.
    Diabetes Care. 2017;40:e115.
    PubMed     Text format    

  26. ITO D, Shimizu S, Inoue K, Saito D, et al
    Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial.
    Diabetes Care. 2017 Jul 27. pii: dc170518. doi: 10.2337/dc17-0518.
    PubMed     Text format     Abstract available

  27. LIU TL, Barritt AS 4th, Weinberger M, Paul JE, et al
    Impact of Physician Specialty Mix on the Outcomes of Patients Dually Diagnosed With Diabetes and Compensated Cirrhosis.
    Diabetes Care. 2017 Jul 26. pii: dc170706. doi: 10.2337/dc17-0706.
    PubMed     Text format    

  28. MUMME L, Breuer TGK, Rohrer S, Schenker N, et al
    Defects in alpha-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals.
    Diabetes Care. 2017 Jul 27. pii: dc170792. doi: 10.2337/dc17-0792.
    PubMed     Text format     Abstract available

  29. NACHUM Z, Yefet E
    Response to Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332-337.
    Diabetes Care. 2017;40:e116.
    PubMed     Text format    


    Diabetes Educ

  30. BECK J, Greenwood DA, Blanton L, Bollinger ST, et al
    2017 National Standards for Diabetes Self-management Education and Support.
    Diabetes Educ. 2017 Jul 1:145721717722968. doi: 10.1177/0145721717722968.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  31. HEALD AH, Livingston M, Malipatil N, Becher M, et al
    Improving Type 2 Diabetes Mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Diabetes Obes Metab. 2017 Jul 20. doi: 10.1111/dom.13067.
    PubMed     Text format     Abstract available

  32. SCHMITT C, Portron A, Jadidi S, Sarkar N, et al
    Pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 in people with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2017 Jul 20. doi: 10.1111/dom.13024.
    PubMed     Text format     Abstract available

  33. PARTHSARATHY V, Hogg C, Flatt PR, O'Harte FPM, et al
    Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
    Diabetes Obes Metab. 2017 Jul 20. doi: 10.1111/dom.13068.
    PubMed     Text format     Abstract available

  34. YANG W, Min K, Zhou Z, Li L, et al
    The efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: the GetGoal-L-C randomized trial.
    Diabetes Obes Metab. 2017 Jul 25. doi: 10.1111/dom.13072.
    PubMed     Text format     Abstract available

  35. ROUSSEL R, d'Emden MC, Fisher M, Ampudia-Blasco FJ, et al
    Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).
    Diabetes Obes Metab. 2017 Jul 24. doi: 10.1111/dom.13071.
    PubMed     Text format     Abstract available


    Diabetologia

  36. ARON-WISNEWSKY J, Sokolovska N, Liu Y, Comaneshter DS, et al
    The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass.
    Diabetologia. 2017 Jul 21. doi: 10.1007/s00125-017-4371.
    PubMed     Text format     Abstract available

  37. HOLST C, Becker U, Jorgensen ME, Gronbaek M, et al
    Alcohol drinking patterns and risk of diabetes: a cohort study of 70,551 men and women from the general Danish population.
    Diabetologia. 2017 Jul 27. doi: 10.1007/s00125-017-4359.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  38. CHEN Q, Ma Q, Wu C, Tan F, et al
    Macular Vascular Fractal Dimension in the Deep Capillary Layer as an Early Indicator of Microvascular Loss for Retinopathy in Type 2 Diabetic Patients.
    Invest Ophthalmol Vis Sci. 2017;58:3785-3794.
    PubMed     Text format     Abstract available

  39. LIM LS, Chee ML, Cheung CY, Wong TY, et al
    Retinal Vessel Geometry and the Incidence and Progression of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:BIO200-BIO205.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  40. TAGGART DP, Benedetto U
    Diabetes Status and Graft Patency After Coronary Bypass Surgery: Is There a Diabetes Paradox?
    J Am Coll Cardiol. 2017;70:525-526.
    PubMed     Text format    

  41. RAZA S, Blackstone EH, Houghtaling PL, Rajeswaran J, et al
    Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency.
    J Am Coll Cardiol. 2017;70:515-524.
    PubMed     Text format     Abstract available


    J Am Soc Nephrol

  42. ZHANG MZ, Wang X, Yang H, Fogo AB, et al
    Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.
    J Am Soc Nephrol. 2017 Jul 24. pii: ASN.2017010107. doi: 10.1681/ASN.2017010107.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  43. FLEISCHER J, Laugesen E, Cichosz SL, Hoeyem P, et al
    Continuous glucose monitoring adds information beyond HbA1c in well-controlled diabetes patients with early cardiovascular autonomic neuropathy.
    J Diabetes Complications. 2017 Jun 30. pii: S1056-8727(17)30508.
    PubMed     Text format     Abstract available

  44. ALZAHRANI S, Nelson J, Moss SF, Paulus JK, et al
    H. pylori seroprevalence and risk of diabetes: An ancillary case-control study nested in the diabetes prevention program.
    J Diabetes Complications. 2017 Jun 3. pii: S1056-8727(17)30525.
    PubMed     Text format     Abstract available

  45. ROUMELIOTIS S, Roumeliotis A, Panagoutsos S, Giannakopoulou E, et al
    Matrix Gla protein T-138C polymorphism is associated with carotid intima media thickness and predicts mortality in patients with diabetic nephropathy.
    J Diabetes Complications. 2017 Jun 30. pii: S1056-8727(16)30786.
    PubMed     Text format     Abstract available


    JAMA

  46. ZHENG Y, Manson JE, Yuan C, Liang MH, et al
    Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life.
    JAMA. 2017;318:255-269.
    PubMed     Text format     Abstract available


    Kidney Int

  47. LIANG G, Song L, Chen Z, Qian Y, et al
    Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30353.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol


  48. Correction to Lancet Diabetes Endocrinol 2017; 5: 597-609.
    Lancet Diabetes Endocrinol. 2017;5:e5.
    PubMed     Text format    


  49. Correction to Lancet Diabetes Endocrinol 2017; 5: 569-71.
    Lancet Diabetes Endocrinol. 2017;5:e5.
    PubMed     Text format    

  50. THE LANCET DIABETES ENDOCRINOL
    Forging paths to improve diabetes care in low-income settings.
    Lancet Diabetes Endocrinol. 2017;5:565.
    PubMed     Text format    

  51. STEHOUWER CDA, van Sloten TT
    Microvascular outcomes in type 2 diabetes.
    Lancet Diabetes Endocrinol. 2017;5:579.
    PubMed     Text format    

  52. ZOUNGAS S, Gerstein HC, Holman RR, Reaven P, et al
    Microvascular outcomes in type 2 diabetes - Authors' reply.
    Lancet Diabetes Endocrinol. 2017;5:580.
    PubMed     Text format    


    Metabolism

  53. KUNUTSOR SK, Kieneker LM, Bakker SJL, James RW, et al
    Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent - paraoxonase-1: The prospective cohort PREVEND study.
    Metabolism. 2017;73:43-51.
    PubMed     Text format     Abstract available

  54. WU C, Qiu S, Zhu X, Li L, et al
    Vitamin D supplementation and glycemic control in type 2 diabetes patients: A systematic review and meta-analysis.
    Metabolism. 2017;73:67-76.
    PubMed     Text format     Abstract available


    N Engl J Med


  55. More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:403-5.
    PubMed     Text format    

  56. HALLER M, Atkinson M, Schatz D
    More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:403.
    PubMed     Text format    


  57. Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:405.
    PubMed     Text format    


    Pediatr Diabetes

  58. ELBARBARY NS, Ismail EAR, El-Naggar AR, Hamouda MH, et al
    The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo-controlled trial.
    Pediatr Diabetes. 2017 Jul 26. doi: 10.1111/pedi.12564.
    PubMed     Text format     Abstract available

  59. PARKKOLA A, Harkonen T, Ryhanen SJ, Uibo R, et al
    Transglutaminase antibodies and celiac disease in children with type 1 diabetes and in their family members.
    Pediatr Diabetes. 2017 Jul 26. doi: 10.1111/pedi.12563.
    PubMed     Text format     Abstract available

  60. AGRAWAL S, Kremsdorf R, Uysal S, E Fredette M, et al
    Nephrolithiasis: A complication of pediatric diabetic ketoacidosis.
    Pediatr Diabetes. 2017 Jul 24. doi: 10.1111/pedi.12559.
    PubMed     Text format     Abstract available


    PLoS One

  61. NGALA RA, Fondjo LA, Gmagna P, Ghartey FN, et al
    Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study.
    PLoS One. 2017;12:e0181613.
    PubMed     Text format     Abstract available

  62. SHIN HJ, Kim TO, Oh HJ, Park HY, et al
    Impact of diabetes mellitus on indeterminate results of the QuantiFERON TB Gold In-Tube test: A propensity score matching analysis.
    PLoS One. 2017;12:e0181887.
    PubMed     Text format     Abstract available

  63. ALGHAMDI M, Al-Mallah M, Keteyian S, Brawner C, et al
    Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: The Henry Ford ExercIse Testing (FIT) project.
    PLoS One. 2017;12:e0179805.
    PubMed     Text format     Abstract available

  64. TSAI FJ, Chen SY, Liu YC, Liao HY, et al
    The comparison of CHCA solvent compositions for improving LC-MALDI performance and its application to study the impact of aflatoxin B1 on the liver proteome of diabetes mellitus type 1 mice.
    PLoS One. 2017;12:e0181423.
    PubMed     Text format     Abstract available

  65. GARCIA TS, Rech TH, Leitao CB
    Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies.
    PLoS One. 2017;12:e0180911.
    PubMed     Text format     Abstract available

  66. THIVOLET C, Vial G, Cassel R, Rieusset J, et al
    Reduction of endoplasmic reticulum- mitochondria interactions in beta cells from patients with type 2 diabetes.
    PLoS One. 2017;12:e0182027.
    PubMed     Text format     Abstract available

  67. ELISSEN AMJ, Hertroijs DFL, Schaper NC, Bosma H, et al
    Differences in biopsychosocial profiles of diabetes patients by level of glycaemic control and health-related quality of life: The Maastricht Study.
    PLoS One. 2017;12:e0182053.
    PubMed     Text format     Abstract available

  68. XU F, Wang KY, Wang N, Li G, et al
    Modified human glucagon-like peptide-1 (GLP-1) produced in E. coli has a long-acting therapeutic effect in type 2 diabetic mice.
    PLoS One. 2017;12:e0181939.
    PubMed     Text format     Abstract available

  69. SONTHON P, Promthet S, Changsirikulchai S, Rangsin R, et al
    The impact of the quality of care and other factors on progression of chronic kidney disease in Thai patients with Type 2 Diabetes Mellitus: A nationwide cohort study.
    PLoS One. 2017;12:e0180977.
    PubMed     Text format     Abstract available

  70. ROSSEN J, Buman MP, Johansson UB, Yngve A, et al
    Reallocating bouted sedentary time to non-bouted sedentary time, light activity and moderate-vigorous physical activity in adults with prediabetes and type 2 diabetes.
    PLoS One. 2017;12:e0181053.
    PubMed     Text format     Abstract available

  71. VAN DYKE AL, Lang Kuhs KA, Shiels MS, Koshiol J, et al
    Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.
    PLoS One. 2017;12:e0182359.
    PubMed     Text format     Abstract available

  72. DOWER K, Zhao S, Schlerman FJ, Savary L, et al
    High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy.
    PLoS One. 2017;12:e0181861.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: